Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China’s National Reimbursement Drug List
      Biotech

      Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China’s National Reimbursement Drug List

      November 28, 2024
      New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List
      Biotech

      New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List

      November 28, 2024
      Kelun-Biotech’s TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC
      Biotech

      Kelun-Biotech’s TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC

      November 27, 2024
      Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment for Cognitive Impairment Associated with Schizophrenia
      Biotech

      Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment for Cognitive Impairment Associated with Schizophrenia

      November 26, 2024
      J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment ‘JIN-001’ – Enhancing Radiation and Chemotherapy Efficacy
      Biotech

      J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment ‘JIN-001’ – Enhancing Radiation and Chemotherapy Efficacy

      November 25, 2024
      Novo Holdings to acquire Benchmark Genetics, a leader in aquaculture genetics
      Biotech

      Novo Holdings to acquire Benchmark Genetics, a leader in aquaculture genetics

      November 25, 2024
      Daiichi Sankyo Joins LabCentral Community as Platinum Sponsor
      Biotech

      Daiichi Sankyo Joins LabCentral Community as Platinum Sponsor

      November 23, 2024
      Global Coalition for Adaptive Research Announces Evaluation of AZD1390 in GBM AGILE Trial
      Biotech

      Global Coalition for Adaptive Research Announces Evaluation of AZD1390 in GBM AGILE Trial

      November 23, 2024
      FDA Roundup: November 22, 2024
      Biotech

      FDA Roundup: November 22, 2024

      November 23, 2024
      Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA
      Biotech

      Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA

      November 22, 2024
      « 1 … 74 75 76 77 78 … 151 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026